Aclaris Therapeutics And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments [Yahoo! Finance]
ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs [Yahoo! Finance]